The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complex
about
Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A2.Recent developments in structural studies on acetylcholinesterase.Detect, correct, retract: How to manage incorrect structural models.Crystal structure of nonspecific lipid transfer protein from Solanum melongena.Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues.
P2860
The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complex
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The impact of crystallization ...... e/acetylcholinesterase complex
@en
The impact of crystallization ...... /acetylcholinesterase complex.
@nl
type
label
The impact of crystallization ...... e/acetylcholinesterase complex
@en
The impact of crystallization ...... /acetylcholinesterase complex.
@nl
prefLabel
The impact of crystallization ...... e/acetylcholinesterase complex
@en
The impact of crystallization ...... /acetylcholinesterase complex.
@nl
P2093
P2860
P356
P1433
P1476
The impact of crystallization ...... e/acetylcholinesterase complex
@en
P2093
Clifford Felder
Esther Roth
Israel Silman
Joel L Sussman
Lev Weiner
Robbie P Joosten
Valery Shnyrov
Yacov Ashani
P2860
P304
P356
10.1002/PRO.2923
P50
P577
2016-03-14T00:00:00Z